Purinethol
Noun: A chemotherapy drug, also known by its generic name mercaptopurine, used primarily to treat acute lymphocytic leukemia (ALL). It belongs to a class of medications called antimetabolites, which work by interfering with the metabolism and synthesis of purines, essential components of DNA and RNA, thereby inhibiting the growth of cancer cells.
This word is a proper noun (a trademark/brand name) for a specific pharmaceutical drug. It is used in medical contexts, particularly in oncology and pharmacology. * The patient was prescribed Purinethol as part of the maintenance therapy for leukemia. * Purinethol (mercaptopurine) is listed as an essential medicine by the World Health Organization.
- The term is often followed by its generic name in parentheses for clarity in medical documentation: Purinethol (mercaptopurine).
- It is typically used with verbs like and .
- Mercaptopurine (6-MP): The generic, non-proprietary name for the same drug.
- Antimetabolite: The class of drugs to which Purinethol belongs.
- Chemotherapeutic agent: A broader term for cancer-treatment drugs.
- Mercaptopurine
- 6-Mercaptopurine (6-MP)
- (There are no direct conceptual synonyms, only the generic name and chemical name.)
This word has only one specific meaning: it is the trademark for a particular antineoplastic (anti-cancer) medication. It does not have different meanings in other contexts.
- a drug (trade name Purinethol) that interferes with the metabolism of purine and is used to treat acute lymphocytic leukemia